|
About Diabetes
|
Diabetes Breakthrough For Reversing Type 1 Diabetes Some cases of neonatal diabetes result from activating
mutations in the ATP-sensitive potassium channel (K-ATP), an international
research team reports. Their studies suggest that sulfonylurea treatment may
restore insulin secretion in such patients. Before this discovery children with this type of diabetes would have to take insulin injections for the rest of their life. But the Peninsula Medical School team, working with scientists throughout the world, have shown that patients with the genetic type of diabetes can respond to sulfonylurea tablets. They are normally used by elderly patients with diabetes and had never been considered in children who were not secreting any insulin. The research was led by Professor Andrew Hattersley and funded by the Wellcome Trust and Diabetes UK. The findings were published in the New England Journal of Medicine. Prof Hattersley said: "We have shown that more than one third of patients diagnosed with diabetes before the age of six months will have diabetes because of a change in the potassium channel gene. "It is very exciting that finding the cause of the diabetes in
these children has resulted in the real possibility of stopping insulin
injections." Source: Diabetes In Control.com: N Engl J Med 2004;350:18171818,1838-1849.
|